Clinical Trials in Pennsylvania

Showing 8681-8700 of 19,675 trials

3D Prediction of Patient-Specific Response

NCT03561207

This is a prospective, non-randomized, observational registry study evaluating a patient-specific ex vivo 3D (EV3D) assay for drug response using a patient's own biopsy or resected tumor tissue for assessing tissue response to therapy in patients with advanced cancers, including ovarian cancer, high-grade gliomas, and high-grade rare tumors.

Advanced CancerOvarian CancerGlioblastoma Multiforme+1 more

KIYATEC570 participantsStarted Jun 2018

Little Rock, Arkansas, United States • San Francisco, California, United States • Trenton, New Jersey, United States +6 more locations

COMPLETEDNA40 miles

Effectiveness of 10-minute Chair Massage Versus 10-minute Break to Reduce Stress and Improve Well-being

NCT04787107

The purpose of this study is to examine the effectiveness of 10-minute chair massage therapy in comparison to a scheduled 10-minute break to evaluate the impact on perceived quality of life, heart rate, blood pressure, and pain scale in healthcare workers.

Stress, PsychologicalFatigueQuality of Life

Geisinger Clinic36 participantsStarted Aug 2021

Danville, Pennsylvania, United States

COMPLETEDPhase 361 miles

An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma

NCT02726581

The purpose of this study is to evaluate the safety and effectiveness of several combination therapies for Multiple Myeloma. Upon entry into the study, patients will be randomized (assigned by chance) to receive either: Group 1: nivolumab, pomalidomide and dexamethasone OR Group 2: pomalidomide and dexamethasone OR Group 3: nivolumab, elotuzumab, pomalidomide and dexamethasone. Enrollment is closed for all groups.

Multiple Myeloma

Bristol-Myers Squibb170 participantsStarted Aug 2016

Birmingham, Alabama, United States • Mobile, Alabama, United States • Fayetteville, Arkansas, United States +118 more locations

3D Prediction of Patient-Specific Response

Effectiveness of 10-minute Chair Massage Versus 10-minute Break to Reduce Stress and Improve Well-being

An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma

Find Trials by Condition in Pennsylvania

Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis

An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer

A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)

Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease

Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer

Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

A Randomized Study to Determine the Expression of the Furin Protein in Patients With SARS-CoV-2 and Vaccinated Against Coronavirus